Sputnik V is the third such vaccine that has received emergency use approval from the drug regulator for corona vaccination in India. (Cipher photo)
First batch of vaccine made at Baddi in Himachal Pradesh will be sent to Moscow for quality control check
Export of vaccine will also be to other countries fighting against Corona RDIF CEO Kirill Dmitriev has said that the introduction of Sputnik V vaccine in India will help defeat Corona as soon as possible. Later this vaccine will be exported to other countries fighting against Corona. Apart from Panacea Biotech, RDIF has also tied up with Hyderabad-based company Dr. Reddy’s Lab for the production of this vaccine. Also read: Great demand for gilt fund, you too can be rich by putting money in it, know everything Sputnik V vaccine is 97.6 percent effective Emergency use of Sputnik V vaccine was approved in India on 12 April 2021. In April, while announcing the agreement for the production of this vaccine, Panacea Biotech and RDIF said that an agreement has been made for production of 100 million doses in India every year. Sputnik V vaccine has been approved in 66 countries around the world, in which 3.2 billion people live. In the investigation, Sputnik V vaccine has been found to be 97.6 percent effective.